Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The relationship between the C825T polymorphism of GNB3 (encoding G-protein β3 subunit) and pre-eclampsia risk is unclear.
Objective: To systematically explore the association between GNB3 C825T and pre-eclampsia.
Search Strategy: PubMed, EMBASE, Google Scholar, and Chinese National Knowledge Infrastructure (CNKI) databases were searched to September 1, 2020, using keywords including "GNB3 C825T" and "pre-eclampsia".
Selection Criteria: Case-control and cohort studies investigating the relationship between GNB3 C825T polymorphism and pre-eclampsia were included.
Data Collection And Analysis: Two reviewers collected the data independently and calculate odds ratios (ORs) with 95% confidence intervals (CIs).
Main Results: The meta-analysis involved eight studies from seven publications, including 2071 cases and 3419 controls. Overall analysis showed that GNB3 C825T was associated with increased pre-eclampsia risk in the recessive model (OR, 1.21; 95% CI, 1.01-1.44; P = 0.04). Subgroup analysis stratified by Hardy-Weinberg equilibrium revealed a relationship between GNB3 C825T and increased risk of pre-eclampsia in the allelic (OR, 1.66; 95% CI, 1.34-2.05; P < 0.001), homozygous (OR, 2.12, 95% CI, 1.04-4.32; P = 0.04), dominant (OR, 1.91; 95% CI, 1.18-3.11; P = 0.009), and recessive (OR, 1.70; 95% CI, 1.03-2.81; P = 0.04) models.
Conclusions: Maternal GNB3 C825T polymorphism seems to be a risk factor for pre-eclampsia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ijgo.13560 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background And Aim: Herbal products are widely used to treat patients with disorders of gut brain interaction but clinical efficacy and safety data for treatments lasting >4 weeks are widely lacking. We evaluated the efficacy and safety of 8 weeks of treatment with the herbal combination product STW 5-II for patients with functional dyspepsia (FD) meeting Rome II criteria. We also conducted a post hoc analysis including patients meeting Rome IV criteria for FD and evaluated the effect of the G-protein beta 3 (GNB3) subunit polymorphism (C825T) on therapeutic response.
View Article and Find Full Text PDFAssociation polymorphism of guanine nucleotide-binding protein β3 subunit () C825T and insertion/deletion of the angiotensin-converting enzyme () gene with peripartum cardiomyopathy.
Front Cardiovasc Med
April 2023
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University-Dr. Soetomo General Hospital, Surabaya, Indonesia.
Introduction: Peripartum cardiomyopathy (PPCM) is a potentially life-threatening pregnancy-related heart disease. Genetic roles such as gene polymorphisms may relate to the etiology of PPCM. This study analyzes the association between single nucleotide gene polymorphism (SNP) guanine nucleotide-binding protein beta-3 subunit () C825T and insertion/deletion (I/D) of the angiotensin-converting enzyme () gene with the incidence of PPCM.
View Article and Find Full Text PDFMeta-analysis of the genetic association between maternal GNB3 C825T polymorphism and risk of pre-eclampsia.
Int J Gynaecol Obstet
September 2021
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Background: The relationship between the C825T polymorphism of GNB3 (encoding G-protein β3 subunit) and pre-eclampsia risk is unclear.
Objective: To systematically explore the association between GNB3 C825T and pre-eclampsia.
Search Strategy: PubMed, EMBASE, Google Scholar, and Chinese National Knowledge Infrastructure (CNKI) databases were searched to September 1, 2020, using keywords including "GNB3 C825T" and "pre-eclampsia".
Objective: Introduction: All components of the metabolic syndrome (MS) are the risk factors for the cardiovascular diseases, and their combination a great deal accelerates and complicates development of the diseases. Phenotypic expression of MS depends on the interaction of genetic and environmental factors. The aim: The aim is to study the association of metabolic syndrome components with the genotypes of the C825T polymorphism in the GNB3 gene, which allows predicting the risks and determining individual lifestyle and treatment program for the future.
View Article and Find Full Text PDFIntroduction: Arterial hypertension is a complex, multifactorial disease, controlled by genetic and environmental factors.
Objective: Evaluate the genetic susceptibility for developing arterial hypertension and its association with the traditional risk factors in the outbreak of this pathology.
Material And Methods: Case-control study with 1712 individuals, mean age of 51.